header-logo
Pancreatic Cancer Hero
Pancreatic Cancer

Expanded Access Programs

At MCW, we are committed to helping patients explore every possible treatment option. Expanded access programs may provide a pathway for patients to receive investigational therapies when they are not eligible for a clinical trial, and no other effective treatments are available. Our expanded access initiatives, led by Dr. Kamgar, work closely with physicians, patients, and industry partners to help guide this process and ensure patients are supported every step of the way.
Kamgar talking_SplitTextComponent

More Information

Overview

Overview

The Medical College of Wisconsin (MCW) is committed to providing patients with access to the most promising treatment options available. For some patients with pancreatic cancer, an investigational therapy may be available through an Expanded Access Program (EAP), also known as compassionate use. Expanded Access allows eligible patients to receive certain investigational drugs, biologics, or medical devices outside of a clinical trial when no satisfactory treatment options exist and participation in an appropriate clinical trial is not possible. Expanded Access is not a clinical trial. Instead, it is a pathway that may provide access to promising therapies while they are still being evaluated for safety and effectiveness.
Expanded Access vs Clinical Trial

Expanded Access vs Clinical Trial

While both Expanded Access and clinical trials involve investigational therapies, they serve different purposes.

Clinical Trials

  • Designed to evaluate the safety and effectiveness of a treatment
  • Follow a specific research protocol
  • Collect data to advance medical knowledge
  • Have defined eligibility criteria
  • Often include multiple participants

Expanded Access

  • Intended to provide treatment access for individual patients or groups of patients
  • Available when a suitable clinical trial is not an option
  • Focuses primarily on patient care rather than research
  • Requires approval from the therapy sponsor and regulatory oversight bodies
  • May not be available for all investigational therapies

Whenever possible, participation in a clinical trial remains the preferred pathway because it helps advance scientific knowledge while providing access to new treatments.

Frequently Asked Questions

Frequently Asked Questions

Can anyone request Expanded Access?
No. Expanded Access is typically reserved for patients with serious or life-threatening conditions who do not have satisfactory treatment alternatives and cannot participate in an appropriate clinical trial.

Is Expanded Access the same as joining a clinical trial?
No. Clinical trials are research studies designed to answer scientific questions. Expanded Access is intended to provide treatment access outside of a research study.

Will I automatically qualify if I am not eligible for a clinical trial?
No. Additional eligibility requirements apply, and the therapy sponsor must agree to provide access.

Are all investigational treatments available through Expanded Access?
No. Availability depends on the sponsor, regulatory requirements, safety considerations, and supply of the investigational product.

Expanded Access Programs

  • ELI-002-102

    Subjects With KRAS/NRAS Mutated Pancreatic Ductal Adenocarcinoma. Enrollment Status: Not Accepting

© 2026 Medical College of Wisconsin.  All rights reserved.  | Terms and Privacy | Web Accessibility Statement

Non-Discrimination, Anti-Harassment, and Legal Compliance Statement
The Medical College of Wisconsin (MCW) is committed to fostering a diverse community of outstanding faculty, staff, and students, as well as ensuring equal educational opportunity, employment, and access to services, programs, and activities, without regard to an individual's race, color, national origin, religion, age, disability, sex, gender identity/expression, sexual orientation, marital status, pregnancy, predisposing genetic characteristic, military status, or other legally protected classification. MCW maintains full compliance with all applicable federal, state, and local laws and regulations in pursuit of our missions. Consistent with federal guidance, we affirm our commitment to individual merit, fairness, and equal treatment in all aspects of academic and institutional decision-making.

MCW's policies, federal and state laws, and regulations prohibit unlawful discrimination and harassment. Employees, learners, students, applicants, or other members of the MCW community (including but not limited to vendors, visitors, and guests) may not be subjected to harassment that is prohibited by law or treated adversely or retaliated against based upon a protected characteristic.